Categories: Uncategorized

VK Paul says we respect FDA’s decision on Covaxin

Dr VK Paul, Member Health, NITI Aayog said on Friday that he respects USFDA’s decision of rejecting Emergency Use Authorization (EUA) for Covaxin. He added that while every country’s regulatory system might have some things in common with others, there are things which are different.

“Scientific framework is same but its nuancing is as per context”, Dr Paul explained when asked about the US FDA’s rejection of EUA for Covaxin.

“All of these are scientific considerations & keeping those in mind, the nuancing might be different, especially in those countries where science is strong. Our manufacturing is strong. They have decided this, we respect it”, he added.

FDA rejected Ocugen’s application for EUA of Covaxin, following which  Bharat Biotech’s US partner on June 10 said it would no longer pursue an emergency use authorisation for Covaxin, and would instead aim to file for a full US approval of the anti-COVID shot.

“This is a consequence of the US FDA asking the company to launch an additional trial so that the company can file for a Biologics Licence Application (BLA), which is a full approval,” said the company.

Medically Speaking Team

Recent Posts

THE HIDDEN CHALLENGE OF WEIGHT LOSS: HOW FAT CELLS “REMEMBER” OBESITY

Losing weight is a significant milestone, but for many, the bigger battle lies in keeping…

18 hours ago

LINDT CHOCOLATE CONTROVERSY: HEAVY METALS DISCOVERED IN POPULAR BRAND’S PRODUCTS

In recent months, a growing controversy has surfaced regarding the presence of heavy metals—specifically lead…

19 hours ago

THE SURPRISING BENEFITS OF VITAMIN B3 IN LOWERING DEATH RISK AND IMPROVING HEART HEALTH

A new study published in Scientific Reports has shed light on the potential benefits of dietary…

19 hours ago

WOMEN’S HEALTH: HOW EXCESS ZINC CAN DISRUPT MENSTRUAL CYCLE AND FERTILITY

Zinc is an essential mineral that plays a crucial role in maintaining overall health. Known…

21 hours ago

AIIMS- LED TRIAL FINDS OPTIMAL DRUG COMBINATION FOR HYPERTENSION PATIENTS

A groundbreaking clinical trial, spearheaded by a team of Indian and international experts, has shed…

21 hours ago

LINK BETWEEN COVID-19 INFECTION AND CANCER REGRESSION UNCOVERED IN A GROUNDBREAKING DISCOVERY

In an unprecedented discovery, scientists have uncovered a surprising connection between COVID-19 infections and the…

23 hours ago